DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE

DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE was reported 947 times

DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MONONUCLEAR CELL COUNT ABNORMAL 1 0.0137
1 MICROCYTOSIS 1 0.0040
2 IMPLANT SITE DISCHARGE 1 0.0027
3 LOWER RESPIRATORY TRACT INFECTION FUNGAL 1 0.0026
4 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
5 MUCOSAL DISCOLOURATION 1 0.0016
6 CONTRAINDICATED DRUG ADMINISTERED 1 0.0014
7 OESOPHAGEAL OBSTRUCTION 1 0.0012
8 LIGAMENT INJURY 1 0.0009
9 MUCOSAL HAEMORRHAGE 1 0.0009
10 INTRUSIVE THOUGHTS 1 0.0008
11 CATAPLEXY 1 0.0007
12 BLOOD ELECTROLYTES DECREASED 1 0.0007
13 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
14 MEDICAL DEVICE IMPLANTATION 1 0.0006
15 ANALGESIC DRUG LEVEL INCREASED 1 0.0006
16 MEDICAL DEVICE REMOVAL 1 0.0006
17 SLEEP TERROR 2 0.0005
18 RENAL NEOPLASM 1 0.0005
19 CARDIAC FLUTTER 3 0.0005
20 NECK SURGERY 1 0.0004
21 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
22 BLADDER PAIN 1 0.0003
23 INCOHERENT 2 0.0003
24 LYMPHOCYTE COUNT INCREASED 1 0.0003
25 DYSGRAPHIA 2 0.0003
26 NEAR DEATH EXPERIENCE 1 0.0003
27 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
28 FACE INJURY 1 0.0003
29 SENSATION OF HEAVINESS 1 0.0003
30 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
31 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
32 HALLUCINATIONS, MIXED 1 0.0002
33 NERVE COMPRESSION 2 0.0002
34 HALLUCINATION, VISUAL 4 0.0002
35 ANORECTAL DISCOMFORT 1 0.0002
36 GENERALISED ERYTHEMA 1 0.0002
37 NEUROLOGICAL SYMPTOM 1 0.0002
38 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
39 ENERGY INCREASED 1 0.0002
40 SINUS HEADACHE 1 0.0002
41 SCREAMING 1 0.0002
42 PROCTALGIA 1 0.0002
43 POOR QUALITY DRUG ADMINISTERED 1 0.0002
44 RESPIRATION ABNORMAL 1 0.0001
45 DEFAECATION URGENCY 1 0.0001
46 BLINDNESS TRANSIENT 1 0.0001
47 PARANOIA 2 0.0001
48 NERVOUSNESS 6 0.0001
49 THROAT TIGHTNESS 3 0.0001
50 BLOOD URINE PRESENT 2 0.0001
51 PRODUCT PACKAGING ISSUE 1 0.0001
52 COELIAC DISEASE 1 0.0001
53 BODY TEMPERATURE DECREASED 1 0.0001
54 EYE DISCHARGE 1 0.0001
55 WEIGHT FLUCTUATION 1 0.0001
56 EATING DISORDER 2 0.0001
57 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
58 EXPIRED PRODUCT ADMINISTERED 3 0.0001
59 EYE INFECTION 1 0.0001
60 RESTLESSNESS 3 0.0001
61 PHARYNGITIS 1 0.0001
62 POISONING 1 0.0001
63 PRODUCT COMPLAINT 2 0.0001
64 HAEMATEMESIS 2 0.0001
65 INTRAOCULAR PRESSURE INCREASED 1 0.0001
66 ANAPHYLACTIC SHOCK 2 0.0001
67 DIPLOPIA 2 0.0001
68 EAR INFECTION 2 0.0001
69 ABNORMAL DREAMS 2 0.0001
70 ORAL DISCOMFORT 1 0.0001
71 SINUS TACHYCARDIA 1 0.0001
72 EPISTAXIS 5 0.0001
73 BRAIN FOG 1 0.0001
74 PRODUCT USE COMPLAINT 1 0.0001
75 HALLUCINATION, AUDITORY 1 0.0001
76 HEART RATE INCREASED 6 0.0001
77 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
78 NIGHTMARE 2 0.0001
79 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
80 THIRST 1 0.0001
81 GASTROENTERITIS VIRAL 1 0.0001
82 CRYING 2 0.0001
83 RESTLESS LEGS SYNDROME 1 0.0001
84 PANIC ATTACK 2 0.0001
85 ACCIDENTAL OVERDOSE 2 0.0001
86 FOOT FRACTURE 1 0.0001
87 FEELING JITTERY 1 0.0001
88 GLAUCOMA 1 0.0001
89 CHOKING 1 0.0001
90 ORAL HERPES 1 0.0001
91 WHEEZING 3 0.0001
92 VERTIGO 3 0.0000
93 IMPAIRED WORK ABILITY 1 0.0000
94 FAECES DISCOLOURED 1 0.0000
95 CHROMATURIA 1 0.0000
96 HEART RATE IRREGULAR 1 0.0000
97 PRESYNCOPE 1 0.0000
98 AGEUSIA 1 0.0000
99 HALLUCINATION 3 0.0000
100 LOSS OF CONSCIOUSNESS 5 0.0000
101 RASH GENERALISED 1 0.0000
102 RESPIRATORY TRACT INFECTION 1 0.0000
103 INSOMNIA 10 0.0000
104 ANAPHYLACTIC REACTION 2 0.0000
105 FEELING COLD 1 0.0000
106 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
107 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
108 RED BLOOD CELL COUNT DECREASED 1 0.0000
109 HYPERSOMNIA 1 0.0000
110 DYSSTASIA 1 0.0000
111 BLOOD POTASSIUM DECREASED 1 0.0000
112 APHASIA 1 0.0000
113 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
114 EMOTIONAL DISORDER 1 0.0000
115 SWOLLEN TONGUE 1 0.0000
116 HYPERHIDROSIS 4 0.0000
117 DIZZINESS 15 0.0000
118 LIP SWELLING 1 0.0000
119 SKIN DISORDER 1 0.0000
120 URTICARIA 5 0.0000
121 EYE PRURITUS 1 0.0000
122 HAEMATURIA 1 0.0000
123 VISION BLURRED 4 0.0000
124 RASH MACULAR 1 0.0000
125 HEART RATE DECREASED 1 0.0000
126 LYMPHADENOPATHY 1 0.0000
127 UNDERDOSE 2 0.0000
128 DYSURIA 1 0.0000
129 BRONCHITIS 2 0.0000
130 HYPERSENSITIVITY 5 0.0000
131 EYE SWELLING 1 0.0000
132 DYSARTHRIA 1 0.0000
133 BLOOD GLUCOSE INCREASED 5 0.0000
134 DYSPNOEA 15 0.0000
135 UNEVALUABLE EVENT 2 0.0000
136 DIABETES MELLITUS 2 0.0000
137 BLOOD PRESSURE INCREASED 4 0.0000
138 PALPITATIONS 3 0.0000
139 ABNORMAL BEHAVIOUR 1 0.0000
140 DRUG INTERACTION 4 0.0000
141 FEELING ABNORMAL 6 0.0000
142 EXTRA DOSE ADMINISTERED 1 0.0000
143 DYSKINESIA 1 0.0000
144 RECTAL HAEMORRHAGE 1 0.0000
145 TINNITUS 1 0.0000
146 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
147 ARRHYTHMIA 1 0.0000
148 ANXIETY 6 0.0000
149 OCULAR HYPERAEMIA 1 0.0000
150 DISEASE RECURRENCE 1 0.0000
151 COMA 1 0.0000
152 MIGRAINE 2 0.0000
153 PRODUCTIVE COUGH 1 0.0000
154 BLOOD GLUCOSE DECREASED 1 0.0000
155 DYSPEPSIA 2 0.0000
156 DRY EYE 1 0.0000
157 THERAPY CESSATION 1 0.0000
158 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
159 VOMITING 9 0.0000
160 MUSCULOSKELETAL PAIN 1 0.0000
161 HYPERTENSION 4 0.0000
162 CONFUSIONAL STATE 3 0.0000
163 TREMOR 3 0.0000
164 NECK PAIN 1 0.0000
165 EYE PAIN 1 0.0000
166 ASTHMA 2 0.0000
167 EYE IRRITATION 1 0.0000
168 NASAL CONGESTION 1 0.0000
169 STOMATITIS 1 0.0000
170 NASOPHARYNGITIS 3 0.0000
171 CHEST PAIN 3 0.0000
172 EXPOSURE DURING PREGNANCY 1 0.0000
173 INTENTIONAL OVERDOSE 1 0.0000
174 SWELLING FACE 1 0.0000
175 PRODUCT DOSE OMISSION 1 0.0000
176 SOMNOLENCE 3 0.0000
177 HEPATIC ENZYME INCREASED 1 0.0000
178 BURNING SENSATION 1 0.0000
179 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
180 RESPIRATORY FAILURE 1 0.0000
181 DEPRESSION 3 0.0000
182 PERIPHERAL SWELLING 2 0.0000
183 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
184 ABDOMINAL DISCOMFORT 2 0.0000
185 BALANCE DISORDER 1 0.0000
186 INTENTIONAL PRODUCT MISUSE 1 0.0000
187 MALAISE 5 0.0000
188 TACHYCARDIA 1 0.0000
189 ADVERSE DRUG REACTION 1 0.0000
190 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
191 SWELLING 1 0.0000
192 GAIT DISTURBANCE 2 0.0000
193 CONTUSION 1 0.0000
194 NAUSEA 8 0.0000
195 SYNCOPE 1 0.0000
196 CONDITION AGGRAVATED 3 0.0000
197 SINUSITIS 1 0.0000
198 ERYTHEMA 2 0.0000
199 ABDOMINAL PAIN UPPER 2 0.0000
200 HAEMORRHAGE 1 0.0000
201 DIARRHOEA 6 0.0000
202 OVERDOSE 2 0.0000
203 PNEUMONIA 3 0.0000
204 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
205 DRUG INEFFECTIVE 12 0.0000
206 FALL 3 0.0000
207 PYREXIA 3 0.0000
208 SEIZURE 1 0.0000
209 BACK PAIN 2 0.0000
210 ABDOMINAL PAIN 2 0.0000
211 CHILLS 1 0.0000
212 OEDEMA PERIPHERAL 1 0.0000
213 PAIN 5 0.0000
214 PRODUCT QUALITY ISSUE 1 0.0000
215 MEMORY IMPAIRMENT 1 0.0000
216 INFECTION 1 0.0000
217 HEADACHE 4 0.0000
218 MYOCARDIAL INFARCTION 1 0.0000
219 COVID-19 1 0.0000
220 NO ADVERSE EVENT 1 0.0000
221 MUSCLE SPASMS 1 0.0000
222 PRODUCT USE ISSUE 1 0.0000
223 ASTHENIA 2 0.0000
224 ARTHRALGIA 2 0.0000
225 RASH 2 0.0000
226 CONSTIPATION 1 0.0000
227 WEIGHT DECREASED 1 0.0000
228 COUGH 1 0.0000
229 PAIN IN EXTREMITY 1 0.0000
230 PRURITUS 1 0.0000
231 FATIGUE 2 0.0000
232 DEATH 1 0.0000
233 OFF LABEL USE 1 0.0000